Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Cancer Vaccines

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Gene Editing of a Carcinogenic Liver Fluke Tetraspanin Impairs Parasite Surface Biogenesis and Extracellular Vesicle Uptake by Human Host Cells.

The Journal of infectious diseases·2025

Same author

Immunomics-guided biomarker discovery for human liver fluke infection and infection-associated cholangiocarcinoma.

Nature communications·2025

Same author

The Anthelmintic Activity of Stonefish (<i>Synanceia</i> spp.) Ichthyocrinotoxins and Their Potential as Novel Therapeutics.

Toxins·2025

Same author

Pharmaceutical Potential of Remedial Plants and Helminths for Treating Inflammatory Bowel Disease.

Pharmaceuticals (Basel, Switzerland)·2024

Same author

Approaches, Strategies and Procedures for Identifying Anti-Inflammatory Drug Lead Molecules from Natural Products.

Pharmaceuticals (Basel, Switzerland)·2024

Same author

Effect of experimental hookworm infection on insulin resistance in people at risk of type 2 diabetes.

Nature communications·2023

Same journal

Whole cell and acellular pertussis vaccines - rethinking the evidence.

Expert review of vaccines·2026

Same journal

Modeling the potential public health and economic impact and cost-effectiveness of vaccination strategies using an adapted COVID-19 vaccine in the Dominican Republic.

Expert review of vaccines·2026

Same journal

Narrative shielding and prebunking: a synergistic strategy against vaccine hesitancy in pediatrics.

Expert review of vaccines·2026

Same journal

Cost-effectiveness and public health impact of RSV immunization for all infants in Japan: a mixed strategy with nirsevimab and RSVpreF.

Expert review of vaccines·2026

Same journal

Post-pandemic impact on the epidemiology of invasive pneumococcal disease: consensus statement from the Latin American Society of Pediatric Infectious Diseases (SLIPE).

Expert review of vaccines·2026

Same journal

Barriers to dengue vaccine uptake in international travelers: a mixed-methods study.

Expert review of vaccines·2026

See all related articles

Search research articles

Related Experiment Video

Updated: Jun 11, 2025

Author Spotlight: Coproparasitoscopic Examination of Dog Stools for Control and Prevention of Zoonotic Parasite Diseases

Author Spotlight: Coproparasitoscopic Examination of Dog Stools for Control and Prevention of Zoonotic Parasite Diseases

Published on: December 15, 2023

Hookworm vaccines: current and future directions.

Eti R Sarkar^1,2, Suchandan Sikder¹, Paul Giacomin¹

¹Australian Institute of Tropical Health and Medicine, James Cook University, Cairns, Queensland, Australia.

Expert Review of Vaccines

|October 1, 2024

Summary

This summary is machine-generated.

An effective hookworm vaccine is crucial for global health, as current treatments like mass drug administration (MDA) do not prevent reinfection. Research shows partial protection from irradiated larvae vaccines, highlighting the need for long-lasting immunity against hookworm infections.

Keywords:

Animal models antigen challenges clinical trials hookworm human challenge immune response vaccine

More Related Videos

Generating Transgenics and Knockouts in Strongyloides Species by Microinjection

Generating Transgenics and Knockouts in Strongyloides Species by Microinjection

Published on: October 7, 2021

Author Spotlight: Advancing Therapeutics to Treat Vibriosis in Humans and Aquatic Organisms

Author Spotlight: Advancing Therapeutics to Treat Vibriosis in Humans and Aquatic Organisms

Published on: May 31, 2024

Related Experiment Videos

Last Updated: Jun 11, 2025

Author Spotlight: Coproparasitoscopic Examination of Dog Stools for Control and Prevention of Zoonotic Parasite Diseases

Author Spotlight: Coproparasitoscopic Examination of Dog Stools for Control and Prevention of Zoonotic Parasite Diseases

Published on: December 15, 2023

Generating Transgenics and Knockouts in Strongyloides Species by Microinjection

Generating Transgenics and Knockouts in Strongyloides Species by Microinjection

Published on: October 7, 2021

Author Spotlight: Advancing Therapeutics to Treat Vibriosis in Humans and Aquatic Organisms

Author Spotlight: Advancing Therapeutics to Treat Vibriosis in Humans and Aquatic Organisms

Published on: May 31, 2024

Area of Science:

Parasitology
Vaccinology
Global Health

Background:

Hookworm infections affect 500 million people globally, causing significant disability.
Mass drug administration (MDA) is a common preventive measure but does not prevent reinfection.
An effective hookworm vaccine is a critical public health need.

Purpose of the Study:

To review recent human studies on hookworm vaccination and infection-treatment strategies.
To summarize the current progress in human and animal model vaccine trials for hookworms.
To emphasize the importance of targeting infective larvae for effective immunity.

Main Methods:

Review of recent human studies involving vaccination with irradiated larvae.
Analysis of repeated infection-treatment rounds to assess partial protection.
Summary of current human and animal model vaccine trials.

Main Results:

Vaccination with irradiated larvae and repeated infection-treatment have shown partial protection.
Studies emphasize targeting infective larvae to prevent adult worm maturation.
Advances in human challenge studies are accelerating vaccine development.

Conclusions:

A hookworm vaccine is essential for long-lasting protection, especially in endemic areas with complex logistics.
Lack of a robust animal model has been a challenge, but human studies show promise.
Vaccine development is critical to overcome limitations of current MDA strategies and provide sterile immunity.